448 related articles for article (PubMed ID: 25599413)
21.
Pang Y; Zong Z; Huo F; Jing W; Ma Y; Dong L; Li Y; Zhao L; Fu Y; Huang H
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739779
[TBL] [Abstract][Full Text] [Related]
22. Resistance to first- and second-line antituberculosis drugs in Southern Taiwan: Implications for empirical treatment.
Kuo CY; Wang WH; Huang CH; Chen YH; Lu PL
J Microbiol Immunol Infect; 2018 Feb; 51(1):88-93. PubMed ID: 28698044
[TBL] [Abstract][Full Text] [Related]
23. In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.
Zhang Z; Li T; Qu G; Pang Y; Zhao Y
Int J Antimicrob Agents; 2015 Jan; 45(1):71-5. PubMed ID: 25459737
[TBL] [Abstract][Full Text] [Related]
24. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
[TBL] [Abstract][Full Text] [Related]
25. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
[TBL] [Abstract][Full Text] [Related]
26. Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
Javaid A; Hasan R; Zafar A; Chaudry MA; Qayyum S; Qadeer E; Shaheen Z; Agha N; Rizvi N; Afridi MZ; Chima MK; Khan AR; Ghafoor A; Khan S; Awan SR; Akhtar S; Choudry K; Iqbal ZH; Ansarie M; Ahmad N
Int J Tuberc Lung Dis; 2017 Mar; 21(3):303-308. PubMed ID: 28225340
[TBL] [Abstract][Full Text] [Related]
27. Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa.
Klopper M; Warren RM; Hayes C; Gey van Pittius NC; Streicher EM; Müller B; Sirgel FA; Chabula-Nxiweni M; Hoosain E; Coetzee G; David van Helden P; Victor TC; Trollip AP
Emerg Infect Dis; 2013 Mar; 19(3):449-55. PubMed ID: 23622714
[TBL] [Abstract][Full Text] [Related]
28. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
[TBL] [Abstract][Full Text] [Related]
29. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
Ei PW; Aung WW; Nyunt WW; Swe TL; Htwe MM; Win SM; Aung ST; Chang CL; Lee HY; Lee JS
Int J Tuberc Lung Dis; 2018 Jan; 22(1):47-53. PubMed ID: 29297425
[TBL] [Abstract][Full Text] [Related]
30. Activity of twelve second-line antimicrobial agents against Mycobacterium tuberculosis in Taiwan.
Lu PL; Peng CF; Hwang JJ; Chen YH
J Chemother; 2008 Apr; 20(2):202-7. PubMed ID: 18467246
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.
Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
BMC Microbiol; 2014 Jun; 14():165. PubMed ID: 24953243
[TBL] [Abstract][Full Text] [Related]
32. A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
Singhal P; Dixit P; Singh P; Jaiswal I; Singh M; Jain A
Indian J Med Res; 2016 Mar; 143(3):341-7. PubMed ID: 27241648
[TBL] [Abstract][Full Text] [Related]
33. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
[TBL] [Abstract][Full Text] [Related]
34. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China].
Shen X; Li J; Gao Q; Xu B; Mei J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519
[TBL] [Abstract][Full Text] [Related]
35. Extensively drug-resistant tuberculosis: current challenges and threats.
Jain A; Mondal R
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
[TBL] [Abstract][Full Text] [Related]
36. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
[TBL] [Abstract][Full Text] [Related]
37. Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
Kempker RR; Kipiani M; Mirtskhulava V; Tukvadze N; Magee MJ; Blumberg HM
Emerg Infect Dis; 2015 Jun; 21(6):992-1001. PubMed ID: 25993036
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of multidrug and extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study.
Wang D; Yang C; Kuang T; Lei H; Meng X; Tong A; He J; Jiang Y; Guo F; Dong M
Jpn J Infect Dis; 2010 Sep; 63(5):368-71. PubMed ID: 20859008
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of extensively drug-resistant tuberculosis in Vladimir and Orel regions, Russia.
Punga VV; Jakubowiak WM; Danilova ID; Somova TR; Volchenkov GV; Kazionnyy BY; Nemtsova ES; Kiryanova EV; Kourbatova EV
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1309-12. PubMed ID: 19793439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]